SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (date of earliest event reported): May 24, 2011
MERCK & CO., INC.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
of incorporation or organization)
|One Merck Drive, P.O. Box 100,
Whitehouse Station, NJ
|(Address of principal executive offices)||(Zip code)|
Registrants telephone number, including area code: (908) 423-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|¨||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|¨||Pre-commencement communications pursuant to Rule 14d2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|¨||Pre-commencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Merck & Co., Inc. (the Company) is filing this Amendment on Form 8K/A to the Companys Current Report on Form 8K dated May 24, 2011, which was filed with the U.S. Securities and Exchange Commission on May 27, 2011 (the Original Report), to disclose the decision of the Board of Directors of the Company regarding how frequently to hold a shareholder non-binding advisory vote on the compensation of the named executive officers. Except for the foregoing, this amendment does not amend, modify or update the disclosures contained in the Original Report.
Item 5.07. Submission of Matters to a Vote of Security Holders
In accordance with the Board of Directors recommendation, and based on the results of the vote reported under Item 5.07 of the Original Report, the Company will hold an annual non-binding advisory vote on the compensation of the named executive officers listed in the proxy statement for its Annual Meeting of Shareholders.
- 2 -
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 12, 2011.
|Merck & Co., Inc.|
|Name:||Katie E. Fedosz|
|Title:||Senior Assistant Secretary|
- 3 -